Mallinckrodt Stock Forecast, Price & News

Wall Street analysts have given Mallinckrodt a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mallinckrodt wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Mallinckrodt plc (NYSE:MNK) posted its quarterly earnings results on Tuesday, August, 4th. The company reported $1.89 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.34 by $0.55. The company earned $700.90 million during the quarter, compared to analyst estimates of $630.19 million. Mallinckrodt had a negative net margin of 89.94% and a positive trailing twelve-month return on equity of 34.26%. The firm's revenue for the quarter was down 14.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.53 earnings per share.
View Mallinckrodt's earnings history.

Some companies that are related to Mallinckrodt include NanoViricides (NNVC), Regulus Therapeutics (RGLS), Monopar Therapeutics (MNPR), Synthetic Biologics (SYN), ABVC BioPharma (ABVC), RenovoRx (RNXT), Cellectar Biosciences (CLRB), Predictive Technology Group (PRED), Rockwell Medical (RMTI), Merrimack Pharmaceuticals (MACK), Synaptogenix (SNPX), Reviva Pharmaceuticals (RVPH), Lotus Pharmaceuticals (LTUS), FSD Pharma (HUGE) and Acasti Pharma (ACST).
View all of MNK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mallinckrodt investors own include Gilead Sciences (GILD), Micron Technology (MU), Bausch Health Companies (BHC), Endo International (ENDP), Teva Pharmaceutical Industries (TEVA), Gerdau (GGB), AT&T (T), Alibaba Group (BABA), (CELG) and Advanced Micro Devices (AMD).

Mallinckrodt trades on the New York Stock Exchange (NYSE) under the ticker symbol "MNK."

One share of MNK stock can currently be purchased for approximately $0.20.

Mallinckrodt has a market capitalization of $16.54 million and generates $3.16 billion in revenue each year. The company earns $-996,500,000.00 in net income (profit) each year or $8.88 on an earnings per share basis.

Mallinckrodt employs 3,400 workers across the globe.

The official website for Mallinckrodt is www.mallinckrodt.com.

Mallinckrodt is headquartered at COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN, DUBLIN 15 L2, D15.

Mallinckrodt's mailing address is COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN, DUBLIN 15 L2, D15. The company can be reached via phone at (531) 696-0000 or via email at [email protected].